Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global GPCR-targeting Drug market was valued at US$ 413.6 million in 2022 and is projected to reach US$ 491.3 million by 2029, at a CAGR of 2.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Reagent Test Kit Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of GPCR-targeting Drug include PerkinElmer, Thermo Fisher Scientific, Merck, BD Biosciences, Molecular Devices, Promega, Qiagen, Abcam and Corning, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
GPCRs or G protein-coupled receptors are proteins located on the cell surface that recognize extracellular substances and transmit signals across the cell membrane. GPCRs do this by activating guanine nucleotide-binding proteins (G protein) that are responsible for signal transduction inside the cell. The signal delivery is very important in various cellular responses including cell growth, gene transcription, post-translational changes, and communication with other cells. This brings on adjustments in the body to adapt to the environmental changes such as increased heart rate when feeling threatened or change in vision in response to dim light.
This report aims to provide a comprehensive presentation of the global market for GPCR-targeting Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GPCR-targeting Drug. This report contains market size and forecasts of GPCR-targeting Drug in global, including the following market information:
Global GPCR-targeting Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the GPCR-targeting Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global GPCR-targeting Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global GPCR-targeting Drug Market Segment Percentages, by Type, 2022 (%)
Reagent Test Kit
Substrate
Global GPCR-targeting Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global GPCR-targeting Drug Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiovascular
Central Nervous
Other
Global GPCR-targeting Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global GPCR-targeting Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies GPCR-targeting Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies GPCR-targeting Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
PerkinElmer
Thermo Fisher Scientific
Merck
BD Biosciences
Molecular Devices
Promega
Qiagen
Abcam
Corning
Discoverx
Cisbio
Outline of Major Chapters:
Chapter 1: Introduces the definition of GPCR-targeting Drug, market overview.
Chapter 2: Global GPCR-targeting Drug market size in revenue.
Chapter 3: Detailed analysis of GPCR-targeting Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of GPCR-targeting Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 GPCR-targeting Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global GPCR-targeting Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global GPCR-targeting Drug Overall Market Size
2.1 Global GPCR-targeting Drug Market Size: 2022 VS 2029
2.2 Global GPCR-targeting Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top GPCR-targeting Drug Players in Global Market
3.2 Top Global GPCR-targeting Drug Companies Ranked by Revenue
3.3 Global GPCR-targeting Drug Revenue by Companies
3.4 Top 3 and Top 5 GPCR-targeting Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies GPCR-targeting Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 GPCR-targeting Drug Players in Global Market
3.6.1 List of Global Tier 1 GPCR-targeting Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 GPCR-targeting Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global GPCR-targeting Drug Market Size Markets, 2022 & 2029
4.1.2 Reagent Test Kit
4.1.3 Substrate
4.2 By Type - Global GPCR-targeting Drug Revenue & Forecasts
4.2.1 By Type - Global GPCR-targeting Drug Revenue, 2018-2023
4.2.2 By Type - Global GPCR-targeting Drug Revenue, 2024-2029
4.2.3 By Type - Global GPCR-targeting Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global GPCR-targeting Drug Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Cardiovascular
5.1.4 Central Nervous
5.1.5 Other
5.2 By Application - Global GPCR-targeting Drug Revenue & Forecasts
5.2.1 By Application - Global GPCR-targeting Drug Revenue, 2018-2023
5.2.2 By Application - Global GPCR-targeting Drug Revenue, 2024-2029
5.2.3 By Application - Global GPCR-targeting Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global GPCR-targeting Drug Market Size, 2022 & 2029
6.2 By Region - Global GPCR-targeting Drug Revenue & Forecasts
6.2.1 By Region - Global GPCR-targeting Drug Revenue, 2018-2023
6.2.2 By Region - Global GPCR-targeting Drug Revenue, 2024-2029
6.2.3 By Region - Global GPCR-targeting Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America GPCR-targeting Drug Revenue, 2018-2029
6.3.2 US GPCR-targeting Drug Market Size, 2018-2029
6.3.3 Canada GPCR-targeting Drug Market Size, 2018-2029
6.3.4 Mexico GPCR-targeting Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe GPCR-targeting Drug Revenue, 2018-2029
6.4.2 Germany GPCR-targeting Drug Market Size, 2018-2029
6.4.3 France GPCR-targeting Drug Market Size, 2018-2029
6.4.4 U.K. GPCR-targeting Drug Market Size, 2018-2029
6.4.5 Italy GPCR-targeting Drug Market Size, 2018-2029
6.4.6 Russia GPCR-targeting Drug Market Size, 2018-2029
6.4.7 Nordic Countries GPCR-targeting Drug Market Size, 2018-2029
6.4.8 Benelux GPCR-targeting Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia GPCR-targeting Drug Revenue, 2018-2029
6.5.2 China GPCR-targeting Drug Market Size, 2018-2029
6.5.3 Japan GPCR-targeting Drug Market Size, 2018-2029
6.5.4 South Korea GPCR-targeting Drug Market Size, 2018-2029
6.5.5 Southeast Asia GPCR-targeting Drug Market Size, 2018-2029
6.5.6 India GPCR-targeting Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America GPCR-targeting Drug Revenue, 2018-2029
6.6.2 Brazil GPCR-targeting Drug Market Size, 2018-2029
6.6.3 Argentina GPCR-targeting Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa GPCR-targeting Drug Revenue, 2018-2029
6.7.2 Turkey GPCR-targeting Drug Market Size, 2018-2029
6.7.3 Israel GPCR-targeting Drug Market Size, 2018-2029
6.7.4 Saudi Arabia GPCR-targeting Drug Market Size, 2018-2029
6.7.5 UAE GPCR-targeting Drug Market Size, 2018-2029
7 GPCR-targeting Drug Companies Profiles
7.1 PerkinElmer
7.1.1 PerkinElmer Company Summary
7.1.2 PerkinElmer Business Overview
7.1.3 PerkinElmer GPCR-targeting Drug Major Product Offerings
7.1.4 PerkinElmer GPCR-targeting Drug Revenue in Global Market (2018-2023)
7.1.5 PerkinElmer Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific GPCR-targeting Drug Major Product Offerings
7.2.4 Thermo Fisher Scientific GPCR-targeting Drug Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck GPCR-targeting Drug Major Product Offerings
7.3.4 Merck GPCR-targeting Drug Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 BD Biosciences
7.4.1 BD Biosciences Company Summary
7.4.2 BD Biosciences Business Overview
7.4.3 BD Biosciences GPCR-targeting Drug Major Product Offerings
7.4.4 BD Biosciences GPCR-targeting Drug Revenue in Global Market (2018-2023)
7.4.5 BD Biosciences Key News & Latest Developments
7.5 Molecular Devices
7.5.1 Molecular Devices Company Summary
7.5.2 Molecular Devices Business Overview
7.5.3 Molecular Devices GPCR-targeting Drug Major Product Offerings
7.5.4 Molecular Devices GPCR-targeting Drug Revenue in Global Market (2018-2023)
7.5.5 Molecular Devices Key News & Latest Developments
7.6 Promega
7.6.1 Promega Company Summary
7.6.2 Promega Business Overview
7.6.3 Promega GPCR-targeting Drug Major Product Offerings
7.6.4 Promega GPCR-targeting Drug Revenue in Global Market (2018-2023)
7.6.5 Promega Key News & Latest Developments
7.7 Qiagen
7.7.1 Qiagen Company Summary
7.7.2 Qiagen Business Overview
7.7.3 Qiagen GPCR-targeting Drug Major Product Offerings
7.7.4 Qiagen GPCR-targeting Drug Revenue in Global Market (2018-2023)
7.7.5 Qiagen Key News & Latest Developments
7.8 Abcam
7.8.1 Abcam Company Summary
7.8.2 Abcam Business Overview
7.8.3 Abcam GPCR-targeting Drug Major Product Offerings
7.8.4 Abcam GPCR-targeting Drug Revenue in Global Market (2018-2023)
7.8.5 Abcam Key News & Latest Developments
7.9 Corning
7.9.1 Corning Company Summary
7.9.2 Corning Business Overview
7.9.3 Corning GPCR-targeting Drug Major Product Offerings
7.9.4 Corning GPCR-targeting Drug Revenue in Global Market (2018-2023)
7.9.5 Corning Key News & Latest Developments
7.10 Discoverx
7.10.1 Discoverx Company Summary
7.10.2 Discoverx Business Overview
7.10.3 Discoverx GPCR-targeting Drug Major Product Offerings
7.10.4 Discoverx GPCR-targeting Drug Revenue in Global Market (2018-2023)
7.10.5 Discoverx Key News & Latest Developments
7.11 Cisbio
7.11.1 Cisbio Company Summary
7.11.2 Cisbio Business Overview
7.11.3 Cisbio GPCR-targeting Drug Major Product Offerings
7.11.4 Cisbio GPCR-targeting Drug Revenue in Global Market (2018-2023)
7.11.5 Cisbio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
